159 related articles for article (PubMed ID: 1233211)
1. The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.
Bergman U; Elmes P; Halse M; Halvorsen T; Hood H; Lunde PK; Sjöqvist F; Wade OL; Westerholm B
Eur J Clin Pharmacol; 1975 Feb; 8(2):83-9. PubMed ID: 1233211
[TBL] [Abstract][Full Text] [Related]
2. Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden.
Griffiths K; McDevitt DG; Andrew M; Baksaas I; Lunde PK; Bergman U; Wessling A; Sjöqvist F
Eur J Clin Pharmacol; 1985; 29(1):1-8. PubMed ID: 4054197
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).
Griffiths K; McDevitt DG; Andrew M; Baksaas I; Helgeland A; Jervell J; Lunde PK; Oydvin K; Agenäs I; Bergman U
Eur J Clin Pharmacol; 1986; 30(5):513-9. PubMed ID: 3530780
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG).
Griffiths K; McDevitt DG; Andrew M; Baksaas I; Helgeland A; Jervell J; Lunde PK; Oydvin K; Agenäs I; Bergman U
Eur J Clin Pharmacol; 1986; 30(5):521-5. PubMed ID: 3758139
[TBL] [Abstract][Full Text] [Related]
5. Regional and international comparison in utilization of antidiabetic drugs.
Stanulović M; Jakovljević V; Kovac T; Lepsanović L; Ducić M
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):254-6. PubMed ID: 3525425
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic drug utilization in hungary.
Hankó B; Tukarcs E; Kumli P; Vincze Z
Pharm World Sci; 2005 Jun; 27(3):263-5. PubMed ID: 16096899
[TBL] [Abstract][Full Text] [Related]
7. Patterns in drug utilization--national and international aspects: antihypertensive drugs.
Baksaas I
Acta Med Scand Suppl; 1984; 683():59-66. PubMed ID: 6146249
[TBL] [Abstract][Full Text] [Related]
8. [Drug consumption in diabetes mellitus (III). Trends of hypoglycemic agents use and consumption in Tarragona, Catalonia, and Spain (1988- 1991). Group for the Study of Diabetes in Tarragona].
Costa B; Hernández JM
Med Clin (Barc); 1993 Apr; 100(15):571-5. PubMed ID: 8497145
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of diabetes in Switzerland: calculation based on drug sales].
Jirovec M; Teuscher A; Bürgi U; Diem P
Schweiz Med Wochenschr; 1993 Nov; 123(47):2247-50. PubMed ID: 8272797
[TBL] [Abstract][Full Text] [Related]
11. A community pharmacy-based survey of antihypertensive and antidiabetic drug dosages in Northern Ireland.
Griffiths K; McDevitt DG
J Clin Hosp Pharm; 1983 Jun; 8(2):115-24. PubMed ID: 6135713
[No Abstract] [Full Text] [Related]
12. Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels.
Melander A; Folino-Gallo P; Walley T; Schwabe U; Groop PH; Klaukka T; Vallano A; Laporte JR; Gallego MR; Schiappa M; Røder M; Kampmann JP; de Swaef A; Aberg M; Månsson NO; Lindblad U
Diabetologia; 2006 Sep; 49(9):2024-9. PubMed ID: 16865360
[TBL] [Abstract][Full Text] [Related]
13. Utilization of antiparkinson drugs in Norway, Sweden, Denmark and Finland 1975-1979.
Aquilonius SM; Granat M; Hartvig P
Acta Neurol Scand; 1981 Jul; 64(1):47-53. PubMed ID: 7324873
[TBL] [Abstract][Full Text] [Related]
14. [Comparisons outpatient drug prescriptions: France, Denmark, Norway, Sweden].
Dezileaux B; Martinez F
Therapie; 2016 Jun; 71(3):297-305. PubMed ID: 27235653
[TBL] [Abstract][Full Text] [Related]
15. Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden.
Magrini N; Einarson T; Vaccheri A; McManus P; Montanaro N; Bergman U
Eur J Clin Pharmacol; 1997; 53(3-4):185-9. PubMed ID: 9476029
[TBL] [Abstract][Full Text] [Related]
16. Differences in antidiabetic drug utilisation between three different health systems in the same national region.
Benítez J; Puerto AM; Díaz JA
Eur J Clin Pharmacol; 1992; 42(2):151-4. PubMed ID: 1618245
[TBL] [Abstract][Full Text] [Related]
17. Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003-2012.
Lisauskienė I; Garuolienė K; Gulbinovič J
Medicina (Kaunas); 2017; 53(4):259-267. PubMed ID: 28844562
[TBL] [Abstract][Full Text] [Related]
18. Treatment of uncomplicated urinary tract infections: exploring differences in adherence to guidelines between three European countries. Drug Education Project Group.
Veninga CC; Lundborg CS; Lagerløv P; Hummers-Pradier E; Denig P; Haaijer-Ruskamp FM
Ann Pharmacother; 2000 Jan; 34(1):19-26. PubMed ID: 10669181
[TBL] [Abstract][Full Text] [Related]
19. Problems in the measurement of psychotropic drug consumption.
Hemminki E
Am J Hosp Pharm; 1982 Feb; 39(2):325-9. PubMed ID: 7058813
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence and consumption of medication in diabetes mellitus in Madrid (1996-2002)].
Arrieta FJ; Calvo MJ; Peréz A; Saavedra P; Cordobés FJ; Cabral R; Arrieta JJ; Rovira A
Rev Clin Esp; 2006 Mar; 206(3):117-21. PubMed ID: 16597376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
